参考文献/References:
[1] 张鑫,刘波,刘辉,等.骨质疏松症的诊断标准及其相关影响因素[J].中医正骨,2012,24(3):33-35.
[2] Godoy Monzón D,Iserson KV,Jauregui J,et al.Total hip arthroplasty for hip fractures:5-year follow-up of functional outcomes in the oldest Independent old and very old patients[J].Geriatr Orthop Surg Rehabil,2014,5(1):3-8.
[3] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南[J].中国骨质疏松杂志,2011,8(3):2.
[4] 宣淼,杨军,李颖,等.唑来膦酸与替勃龙对绝经后骨质疏松症骨密度、骨代谢指标及骨折影响的临床研究[J].中华内分泌代谢杂志,2013,29(6):504-508.
[5] Chao M,Hua Q,Yingfeng Z,et al.Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women[J].Pak J Med Sci,2013,29(6):1381-1384.
[6] Khajuria DK,Razdan R,Mahapatra DR.Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats[J].J Orthop Sci,2014,19(4):646-656.
[7] 黄建武,黄建华,林爱菊.补肾健骨汤合阿伦磷酸钠对绝经后骨质疏松症患者骨密度和性激素水平的影响[J].中医正骨,2013,25(8):30-31.
[8] 林华,徐天舒,范璐,等.5mg唑来膦酸治疗绝经后骨质疏松及其骨折[J].中华创伤骨科杂志,2012,14(1):31-35.
[9] Li CY,Mori S,Li JL,et al.Long-term effect of incadronate disodium(YM-175)on fracture healing of femoral shaft in growing rats[J].J Bone Mineral Research,2001,16(3):429-436.
[10] Sahana H,Khajuria DK,Razdan R,et al.Improvement in bone properties by novel nanoparticle based formulation in a rat model of osteporosis[J].J Biomed Nanotechnol,2013,9(2):193-201.
[11] 聂海,彭超,郝杰,等.唑来膦酸预防绝经妇女骨质疏松性骨折的meta分析[J].第二军医大学学报,2011,32(9):985-990.
[12] Briot K,Cortet B,Thomas T,et al.2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis[J].Joint Bone Spine,2012,79(3):304-313.
[13] 郭艾,罗先正,任素梅,等.股骨假体周围骨密度定量测定[J].中国骨质疏松杂志,1999,5(3):28.
[14] Shen Y,Li XM,Ding YR,et al.Stro-1-positive BMSCs predict postoperative periprosthetic bone mineral density outcomes in uncemented total hip arthroplasty patients[J].Med Sci Monit,2014,20:361-367.
[15] 王博,李玉雄.抗骨疏胶囊治疗原发性骨质疏松症的临床研究[J].中医正骨,2010,22(5):21-23.
相似文献/References:
[1]潘雄,刘其顺,应行,等.中药联合4步康复锻炼法对骨质疏松性椎体压缩
骨折患者生存质量的影响[J].中医正骨,2015,27(04):65.
[2]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(强骨饮颗粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):16.
[3]陈建德,樊晓琦,夏炳江,等.球囊扩张部位对椎体后凸成形术治疗骨质疏松性椎体压缩骨折疗效及安全性的影响[J].中医正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):11.
[4]史晓林,王健,王博,等.脆性骨折的防治进展[J].中医正骨,2017,29(05):20.
[5]朱丽英,胡春艳,孟苗,等.唑来膦酸静脉滴注联合华蟾素胶囊口服治疗转移性骨肿瘤[J].中医正骨,2017,29(07):55.
[6]陈勍,刘钟,陈文亮,等.股骨近端防旋髓内钉固定联合口服仙灵骨葆胶囊治疗肾阳虚型骨质疏松性股骨转子间骨折[J].中医正骨,2017,29(07):69.
[7]曾武,林曙峰,朱俊峰,等.女性骨质疏松性桡骨远端骨折锁定钢板内固定术后腕关节功能恢复的影响因素分析[J].中医正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):39.
[8]丁志清,颜峰,喻灿明,等.椎体后凸成形术后非典型骨水泥植入综合征死亡1例[J].中医正骨,2017,29(11):76.
[9]漆继聪,喻丹.唑来膦酸联合左归丸在预防人工全髋关节置换术后假体无菌性松动中的应用[J].中医正骨,2018,30(01):62.
[10]俞兴,王婷,杨济洲,等.经皮椎体成形术和经皮椎体后凸成形术治疗Kmmell病的对比研究[J].中医正骨,2018,30(06):23.
YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(01):23.